Lawsuit: QC Kinetix Illegally Fails to Disclose Lack of FDA Approval of ‘Worthless’ Stem Cell, Regenerative Treatments
March 27, 2026 A class action lawsuit alleges that QC Kinetix illegally fails to mention that its ‘experimental,’ pricey pain treatment services lack FDA approval.